Change over period
From:
To:
Zoom:
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
CEO | Dr. David Ross Parkinson M.D. |
IPO Date | July 9, 2015 |
Location | Canada |
Headquarters | 999 West Broadway, Vancouver, BC, Canada, V5Z 1K5 |
Employees | 50 |
Sector | Healthcare |
Industry | Biotechnology |
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
StockViz Staff
September 19, 2024
Any question? Send us an email